Novo Nordisk is deploying artificial intelligence to cut regulatory submission timelines from 18 months to just weeks, centralising much of…
Read More

Novo Nordisk is deploying artificial intelligence to cut regulatory submission timelines from 18 months to just weeks, centralising much of…
Read More
The Novo Nordisk Foundation has allocated up to €25 million for the BioInnovation Institute (BII) to launch a new initiative,…
Read More
The Novo Nordisk Foundation is infutilizing a startup incubator it created with additional capital to strengthen innovation and entrepreneurship in…
Read More
Novo Nordisk A/S NVO shares are trading higher Monday after the company announced European Union approval for oral semaglutide to…
Read More